Publicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (7)

2024

  1. EPI-SURVEY: Grade of Awareness Among Spanish Allergists, Hospital Pharmacists, and Pulmonologists of the Relevance of Bronchial Epithelium and Alarmins in the Pathogenesis and Management of Severe Asthma

    Journal of Investigational Allergology and Clinical Immunology, Vol. 34, Núm. 5, pp. 336-338

2022

  1. EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 1, pp. 17-38

2021

  1. Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 45-58

  2. Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 59-70

2018

  1. The prostaglandin D 2 receptor 2 pathway in asthma: A key player in airway inflammation 11 Medical and Health Sciences 1107 Immunology 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology

    Respiratory Research, Vol. 19, Núm. 1

2017

  1. Moving toward consensus on diagnosis and management of severe asthma in adults

    Current Medical Research and Opinion, Vol. 34, Núm. 3, pp. 387-399

  2. dIvergEnt: How IgE axis contributes to the continuum of allergic asthma and anti-IgE therapies

    International Journal of Molecular Sciences, Vol. 18, Núm. 6